ML-SYS / 2026.07NON-CLINICAL RESEARCH MATERIALSORIGIN DECLARED BY LOT

← Compound index

RM-TRS / Tissue, repair and matrix signalling

AHK-Cu

Also known as: Alanine-histidine-lysine copper · L-alanyl-L-histidyl-L-lysine-Cu2+ · Copper tripeptide AHK

Preclinical evidenceEvidence grade C: Preclinical evidence

Grade describes the published research on the molecule. It is not a quality score, a safety score, or a release state.

What this is

AHK-Cu is a metal-peptide complex. A peptide-only mass or purity result is not enough to describe copper occupancy, oxidation state or final complex composition.

Evidence position

The direct record is centered on cultured cells and ex-vivo follicles, supporting Grade C.

What the record does not establish

Ex-vivo elongation and cell-signaling results do not prove a cosmetic or clinical outcome and do not qualify another formulation or batch.

Sources

  • 01
    Effect of AHK-Cu on human hair growth in vitroPubMed
    Shows
    Ex-vivo human hair-follicle and cultured dermal-papilla-cell findings
    Does not show
    Laboratory model only; does not establish clinical outcome, formulation performance or lot quality

External database index

LIVE DATABASE INDEX / SEPARATE FROM CURATED EVIDENCE

Records below come directly from public scientific databases. They help find relevant material, but do not affect the evidence grade until they are matched to the molecule and added to the curated source list.

PUBCHEM / IDENTITY

copper;(2S)-6-amino-2-[[(2S)-2-[(2S)-2-azanidylpropanoyl]azanidyl-3-(1H-imidazol-4-yl)propanoyl]amino]hexanoate;hydrochloride

CID
168431292
Formula
C15H24ClCuN6O4-
Mass
451.39
Open identity record ↗

Related compounds